PeptideDB

NCGC00138783 TFA

NCGC00138783 TFA

CAS No.:

NCGC00138783 TFA is a selective inhibitor targeting the CD47/SIRPα axis with IC50 of 50 μM. NCGC00138783 TFA directly
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

NCGC00138783 TFA is a selective inhibitor targeting the CD47/SIRPα axis with IC50 of 50 μM. NCGC00138783 TFA directly blocks the interaction of CD47 with the SIRPα axis.

Physicochemical Properties


Molecular Formula C28H27F4N7O3S
Related CAS # NCGC00138783;NCGC00138783 free base;896700-07-5
Appearance White to light yellow solid powder
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets CD47/SIRPα axis[1]
References [1]. Junqiao Zhu, et al. CD47-SIRPα axis in cancer therapy: Precise delivery of CD47-targeted therapeutics and design of anti-phagocytic drug delivery systems. Medicine in Drug Discovery. 2022. 15:100139
[2]. Bo Huang, et al. Structural analysis and binding sites of inhibitors targeting the CD47/SIRPα interaction in anticancer therapy. Comput Struct Biotechnol J. 2021 Oct 1;19:5494-5503.

Solubility Data


Solubility (In Vitro) DMSO :~50 mg/mL (~80.96 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1.25 mg/mL (2.02 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)